Atlas Nanotech Opens First Revenue Stream With Gem Labs Contract
CSSI (Costas Inc.), DBA Atlas Nanotech, recently memorialized an agreement with Laboratorios Gem S.A. de C.V. of Mexico City gemlabs.mx. The contract calls for Atlas to sell stabilized and functionalized silver nanoparticles to Gem Labs for use in the manufacture of one of Gem Labs proprietary products. This agreement represents an initial source of income for Atlas with revenue anticipated as soon as Q3 2019.
The contract is understood as a first act of trade between the parties and goes on to define initial terms of a licensing agreement for the use and exploitation of Nanogasa (nanogasa.com), a patented development of Atlas Nanotech.
Professor David de la Mora, Atlas Chairman, said “the production for sale of raw nanotechnology material is a growing industry,” adding, “the acceptance by Gem Labs of our nano material shows that we can produce a stable quality product at a competitive price.”
Gem Labs President Ivan Lopez stated that several other firms had been considered for the contract, however based on a sample provided by Atlas, it was the nano particles produced by Atlas that met the highest standards sought after by Gem Labs for its products.
Dr. Julio César Riestra, CEO of Atlas, said while it is important for Atlas to begin receiving these revenues from the sale of raw nanoparticles, it is of greater consequence for the firms to form a relationship and alliance; in particular, with a company of such stature as Gem Labs. There are many synergies that the two companies can exploit going forward, he said.
About COSTAS Inc. DBA Atlas Nanotech
Costas Inc. has been trading under the symbol CSSI since the year 2014. With the recent acquisition of the Guadalajara-based nano-medical firm Atlas Nanotech, it now enters the new dynamic market of nanotechnology development and manufacturing.
Total Page Views: 1094
